EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Short‐term risks and benefits of hydroxyurea (hydroxycarbamide)‐induced transfusion independence in patients with beta‐thalassaemia syndromes

B R Sevanthini, Santhosh Hegde, Tejashree Sridhar, Deepa Trivedi, Mohan Reddy, Vaibhav Shah, Vidhi Mayur Panchamia, T Geetha, Dharmik Vora, H Pushpa, Rajat Kumar Agarwal iD, Lawrence Faulkner

British Journal of Haematology · 2025

DOI: 10.1111/bjh.70109 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, 2025. Verfasst von B R Sevanthini und 11 weiteren Autor:innen. Beteiligte Einrichtung: Sankalp India Foundation, Bangalore, India. Hauptthemen laut MEDLINE: Hydroxyurea, beta-Thalassemia, Blood Transfusion, Antisickling Agents. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clinical outcomes of hydroxyurea (hydroxycarbamide)-induced transfusion independence in patients with β-thalassaemia syndromes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hydroxyureabeta-ThalassemiaBlood TransfusionAntisickling AgentsHumansMaleFemaleAdultAdolescentYoung AdultMiddle AgedChild

Stichwörter der Autor:innen

fetal haemoglobin (HbF)hydroxyurea (HU; hydroxycarbamide)pulmonary hypertension (PAH)sickle cell anaemia (SCA)transfusion‐dependent thalassaemia (TDT)

Substanzen

HydroxyureaAntisickling Agents

Autor:innen und Institutionen

  • Sankalp India Foundation, Bangalore, India.
  • Jagriti InnoHealth Platforms Pvt. Ltd., Bangalore, India.
  • Cure2Children Foundation, Florence, Italy.

ORCID-Profile: Rajat Kumar Agarwal

Zitieren

APA

Sevanthini, B. R., Hegde, S., Sridhar, T., Trivedi, D., Reddy, M., Shah, V., Panchamia, V. M., Geetha, T., Vora, D., Pushpa, H., Agarwal, R. K., & Faulkner, L. (2025). Short‐term risks and benefits of hydroxyurea (hydroxycarbamide)‐induced transfusion independence in patients with beta‐thalassaemia syndromes. British Journal of Haematology. https://doi.org/10.1111/bjh.70109

Vancouver

Sevanthini BR, Hegde S, Sridhar T, Trivedi D, Reddy M, Shah V, et al. Short‐term risks and benefits of hydroxyurea (hydroxycarbamide)‐induced transfusion independence in patients with beta‐thalassaemia syndromes. British Journal of Haematology. 2025. doi:10.1111/bjh.70109

BibTeX
@article{Sevanthini2025,
  author = {Sevanthini, B R and Hegde, Santhosh and Sridhar, Tejashree and Trivedi, Deepa and Reddy, Mohan and Shah, Vaibhav and Panchamia, Vidhi Mayur and Geetha, T and Vora, Dharmik and Pushpa, H and Agarwal, Rajat Kumar and Faulkner, Lawrence},
  title = {Short‐term risks and benefits of hydroxyurea (hydroxycarbamide)‐induced transfusion independence in patients with beta‐thalassaemia syndromes},
  journal = {British Journal of Haematology},
  year = {2025},
  doi = {10.1111/bjh.70109}
}
Kostenlos starten →